Benefits
Iodine Deficiency Prevention/Treatment
Iodine deficiency is the leading preventable cause of intellectual disability worldwide — affects an estimated 2 billion people in iodine-deficient regions. Universal salt iodization (using KI or potassium iodate) has dramatically reduced cretinism and goiter. Potassium iodide is the standard form for population-level iodine fortification.
Thyroid Protection in Nuclear Emergencies (FDA-Approved)
KI tablets (130 mg KI = 100 mg iodine for adults) are FDA-APPROVED for thyroid protection during radioactive iodine release events (nuclear power plant accidents, dirty bombs). Mechanism: SATURATING the thyroid with stable iodine prevents radioactive iodine-131 uptake. Distributed by federal/state emergency management programs near nuclear facilities.
Hyperthyroidism Pre-Operative Preparation
Lugol's solution (potassium iodide + iodine) is used PRE-OPERATIVELY before thyroid surgery in hyperthyroidism — high-dose iodine reduces thyroid gland vascularity and decreases hormone release (Wolff-Chaikoff effect). Standard endocrine surgery protocol.
Standardized Pharmaceutical
Unlike kelp-derived iodine (variable content, contamination concerns), potassium iodide has precisely-known iodine content and consistent dosing. Pharmaceutical-grade quality assurance. Preferred form for clinical applications.
Sporotrichosis Treatment
Saturated solution of potassium iodide (SSKI) is used for sporotrichosis (fungal infection from rose thorn injuries, sphagnum moss). Older treatment but still used in some settings; itraconazole is now first-line.
Mechanism of action
Thyroid Iodine Uptake
Iodine is concentrated by the thyroid gland (sodium-iodide symporter / NIS) for thyroid hormone synthesis. T3 and T4 contain 3 and 4 iodine atoms respectively. Iodine deficiency impairs thyroid hormone production → goiter (compensatory thyroid enlargement) and hypothyroidism.
Wolff-Chaikoff Effect (High-Dose Iodine)
Acute high-dose iodine (>1 mg/day) transiently inhibits thyroid hormone synthesis — basis for hyperthyroidism pre-op preparation. Most patients escape this effect within 1-2 weeks (Plummer effect); chronic high-dose iodine can cause iodine-induced HYPERTHYROIDISM in susceptible individuals (Jod-Basedow phenomenon).
Radioactive Iodine Blocking
Stable potassium iodide saturates thyroid iodine binding sites, preventing uptake of radioactive I-131 (released in nuclear accidents). Most effective if taken within 4-6 hours of exposure; effectiveness diminishes after 12-24 hours.
Mucolytic and Antifungal Properties
High-dose iodine has mild antifungal activity (basis for sporotrichosis use) and historical mucolytic use (chronic bronchitis); displaced by modern pharmaceuticals.
Clinical trials
Population studies after Chernobyl (1986) examining thyroid cancer rates in areas where KI was vs was not distributed. Polish program distributed KI rapidly; Belarus/Ukraine did not.
Pediatric populations near Chernobyl.
Areas receiving KI prophylaxis had substantially lower pediatric thyroid cancer rates vs non-treated areas. Foundational evidence supporting KI distribution near nuclear facilities. FDA approved KI for radiation emergencies based on this and similar data.
WHO global iodine deficiency disorder elimination programs using iodized salt (potassium iodide or potassium iodate fortification).
Iodine-deficient populations globally.
Universal salt iodization has dramatically reduced goiter prevalence and cretinism in formerly iodine-deficient regions. Cost-effective public health intervention. KI/KIO3 are equivalent for fortification purposes.
About this ingredient
Potassium iodide (KI) is the pharmaceutical/inorganic form of iodine — chemically: K⁺ + I⁻. Iodine content: ~76% by weight (130 mg KI = ~100 mg elemental iodine).
RDA: 150 µg iodine/day adults; 220 µg pregnancy; 290 µg lactation.
UL: 1,100 µg/day adults.
CRITICAL CLINICAL FORMS: (1) IODIZED SALT — typical fortification 40-100 ppm KI; primary global iodine source; (2) KI TABLETS — FDA-approved for radiation emergencies; 130 mg KI = 100 mg iodine for adults; pediatric/infant doses lower; (3) LUGOL'S SOLUTION — 5% iodine + 10% KI in water; pre-operative hyperthyroid preparation; (4) SSKI — saturated solution potassium iodide; sporotrichosis, mucolytic; (5) POTASSIUM IODATE (KIO3) — alternative salt fortification compound; chemically distinct from KI; both effective for iodine delivery.
EVIDENCE-BASED USES: (1) IODINE DEFICIENCY treatment/prevention (foundational WHO program); (2) RADIATION EMERGENCIES (FDA-approved; thyroid blocking); (3) HYPERTHYROIDISM PRE-OP (Wolff-Chaikoff effect); (4) Sporotrichosis (older treatment); (5) Goiter from deficiency.
CRITICAL CAUTIONS: (1) JOD-BASEDOW PHENOMENON — iodine-induced HYPERTHYROIDISM in susceptible individuals (autonomous nodules, multinodular goiter); rapid iodine repletion in iodine-deficient population can trigger thyrotoxicosis; (2) IODINE-INDUCED HYPOTHYROIDISM — Hashimoto's patients particularly susceptible; (3) HASHIMOTO'S/AUTOIMMUNE THYROID — high-dose iodine can WORSEN autoimmune thyroid disease; AVOID supraphysiologic doses; (4) PREGNANCY — RDA needed (220 µg) for fetal thyroid development; HIGH-DOSE crosses placenta and causes fetal hypothyroidism/goiter; do NOT use pharmaceutical KI doses in pregnancy without specialist supervision; (5) IODINE ALLERGY — rare but documented; SHELLFISH ALLERGY MYTH — shellfish allergy is to muscle proteins (tropomyosin), NOT iodine; iodinated contrast media reactions are also not iodine-mediated; (6) POTASSIUM LOAD — KI provides potassium; CKD/hyperkalemia risk; (7) MOST ADULTS in iodine-adequate countries (US uses iodized salt) DO NOT NEED supplemental KI beyond food sources; (8) DRUG INTERACTIONS — lithium (additive antithyroid), amiodarone (high iodine content), antithyroid drugs (additive); (9) For RADIATION EMERGENCY — KI is most effective if taken within 4-6 hours of exposure; effectiveness diminishes after 12-24 hours; consult emergency management.